Right patient, right dose, right time
Peer-Reviewed Publication
Updates every hour. Last Updated: 11-Sep-2025 22:11 ET (12-Sep-2025 02:11 GMT/UTC)
NUS Medicine study uses AI to modify drug doses for personalised cancer treatment
Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have discovered that expansion of mutant blood cells, a phenomenon linked to ageing, can be found in cancerous tumours, and this is associated with worse outcomes for patients.
The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy and some cancers.
Scientists at St. Jude Children’s Research Hospital and the Medical College of Wisconsin have discovered how chemokines and G protein-coupled receptors selectively bind each other to control how cells move.